Ad vaccines have been shown to induce the highest B- and CD8+ T-cell responses in experimental animals, including rodents, canines, and primates against a variety of immunogens derived from a number of infectious agents (e.g., viruses, parasites, or bacterial pathogens) and tumor cells, including tumor-associated antigens (TAAs) [55]. The gene discussed is CD8A; the disease is neoplasm.